Bridgepoint Considers £550m Bid for London-Listed Medical Group AMS
Bridgepoint is reportedly weighing a takeover bid for Advanced Medical Solutions Group (AMS), a medical devices manufacturer listed on London's AIM. The potential offer could value AMS at around £550m to £600m, with a proposed price of 270p to 280p per share, representing a premium of over 30% compared to the current share price.
AMS is known for its surgical brands LiquiBand and Resorba. As of the latest interim results to September, the group reported a 49% increase in pre-tax profit. AMS shares have recently traded near 208.5p, giving it a market capitalization of approximately £455m.
Bridgepoint, also the private equity backer of Burger King UK, has not made any formal approach as of Friday morning. Previous interest in AMS came from Montagu Private Equity, which was abandoned, and Inflexion, which studied a potential offer last year.
